FORBES
A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And Chronic Pain Epidemic
Forbes profiles Brian Meshkin as a Predictive Healthcare Visionary advancing ethical leadership in healthcare and transforming medicine from reactive to proactive through genetics, data, and AI—while tackling chronic pain and the opioid crisis.
FORBES
More Than 1 In 5 Americans Experience Chronic Pain. Here’s What To Know
Forbes examines personalized approaches to pain therapy, highlighting Brian Meshkin and his companies Proove Genomics and Outcomeus, which leverage genetic insights, clinical data, mobile technology, telemedicine, and analytics to advance more predictive and personalized pain care.
FORBES
How Predictive Healthcare Can Improve African American Women’s Experience
Forbes highlights Brian Meshkin’s vision for predictive healthcare as a pathway to more equitable medicine, using data-driven and personalized approaches to improve outcomes and expand access to quality care for underserved communities.
YAHOO FINANCE
America Finds Its Partner in Combating the Opioid Crisis and Chronic Pain with the Launch of Predictive Health Company Outcomeus
Yahoo Finance highlights Brian Meshkin and his companies Proove Genomics and Outcomeus as partners in combating America’s opioid crisis through predictive healthcare, personalized medicine, and data-driven approaches to pain management.
pr news wire
IN THE INTERESTS OF JUSTICE" BRIAN MESHKIN AND PROOVE BIOSCIENCES CLEARED OF ALL CHARGES AS U.S. GOVERNMENT DISMISSES CASE
Brian Meshkin and Proove Biosciences emerged victorious after the U.S. government dismissed its multi-year false case against them “in the interests of justice,” marking a significant legal victory and a milestone for the broader adoption of biomarker testing.
Baltimore Sun
THE BALTIMORE SUN NAMES BRIAN MESHKIN AN “EARTHLY ANGEL” FOR HIS EXTRAORDINARY COMMITMENT TO COMMUNITY SERVICE AND HELPING OTHERS.
The Baltimore Sun named Brian Meshkin an “Earthly Angel,” recognizing his early commitment to community service, social activism, and helping vulnerable individuals. The honor reflected his lifelong dedication to creating positive social impact.
Baltimore Sun
BRIAN MESHKIN ELECTED AS THE YOUNGEST SCHOOL BOARD MEMBER IN ONE OF THE NATION’S MOST PROMINENT SCHOOL DISTRICTS
Brian Meshkin was elected as the youngest member of the Howard County Board of Education, bringing innovation, technology, and community advocacy to one of the nation’s most prominent public school systems.
CNBC
CNBC FEATURES BRIAN MESHKIN’S GENETIC TESTING INNOVATION AS A PROMISING SOLUTION TO AMERICA’S OPIOID CRISIS
CNBC highlighted Brian Meshkin’s work at Proove Genomics, showcasing how genetic testing could personalize pain treatment, reduce opioid misuse, and improve patient outcomes through precision medicine.